The distribution of effective COVID-19 vaccines is likely to be much slower in Africa than in many other parts of the world and the “vaccine bounce” in domestic economic activity will probably also be more muted. Those countries that will benefit the most are the major commodity producers and tourism-dependent economies. Even so, recoveries across the region will probably remain slow-going and the outlook will be clouded by higher debt burdens.
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services